Oscar Health, Inc. 8-K

What Happened
Oscar Health, Inc. (OSCR) filed a Form 8‑K on April 21, 2026 under Regulation FD to reaffirm the full‑year 2026 guidance previously provided in its February 10, 2026 press release for Q4 and full‑year 2025. The company also announced upcoming changes to its Board leadership via a press release furnished as Exhibit 99.1 to the 8‑K. Oscar said it expects to release first quarter 2026 financial results before the market opens on Wednesday, May 6, 2026, and will host a conference call beginning at 8:00 AM ET.

Key Details

• Reaffirmed full‑year 2026 financial guidance originally disclosed in the February 10, 2026 press release.
• Q1 2026 results scheduled for release before market open on May 6, 2026; earnings call at 8:00 AM ET the same day.
• Board leadership changes announced on April 21, 2026; the related press release is furnished as Exhibit 99.1 to the 8‑K.
• The filing includes a broad forward‑looking statement caution listing risks (e.g., medical cost estimates, regulatory changes, profitability, data security, and other factors) and notes the forward‑looking statements speak only as of the date made.

Why It Matters
For investors, the key takeaways are that Oscar is maintaining its previously issued 2026 outlook and preparing investors for its Q1 earnings release on May 6 — a date when management may provide updated financials and commentary. The board leadership changes could affect corporate governance and strategic direction; the press release (Exhibit 99.1) should be reviewed for specifics. The filing’s forward‑looking caution reminds investors that guidance is subject to risks and uncertainties disclosed in Oscar’s SEC filings.